| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO
1 company
O'Day Daniel Patrick is a Chairman &CEO at GILD. Recent filings cover 0 purchases and 31 sales. Those positions are worth an estimated $84.2M at current prices.
Our model assigns O'Day Daniel Patrick a below-average insider score of 40/100, based on 10 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -18.8%.
O'Day Daniel Patrick's largest disclosed position is in GILD as Chairman &CEO, worth about $84.2M. The recent filings there lean toward selling, a net 175,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $147.90 | $2,218,507.50 | -2.6% | - | - | |
| Sep 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $148.64 | $2,229,592.04 | -2.5% | - | - | |
| Aug 3, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $130.31 | $1,954,693.53 | -2.5% | - | - | |
| Jul 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $126.29 | $1,894,399.93 | -2.4% | - | - | |
| Jun 1, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 15,000 | $131.46 | $1,971,846.67 | -2.4% | - | - | |
| Apr 28, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $129.16 | $1,291,608.37 | -1.6% | +0.0% | - | |
| Jan 28, 2026 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $139.89 | $1,398,911.15 | -1.8% | -7.5% | - | |
| Dec 29, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $124.83 | $1,248,272.00 | -1.7% | +9.2% | - | |
| Nov 28, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $126.54 | $1,265,443.77 | -1.7% | +14.2% | - | |
| Oct 28, 2025 | GILD Gilead Sciences, Inc. | Chairman &CEO | Sell | 10,000 | $119.39 | $1,193,925.67 | -1.7% | +16.9% | - |